Literature DB >> 2075789

Diabetes mellitus as presenting feature in extra-adrenal pheochromocytoma: report of a case.

P G Balestrieri1, S Spandrio, G Romanelli, G Giustina.   

Abstract

Secondary diabetes mellitus was the main abnormal finding in a young lean woman with benign extra-adrenal para-aortic norepinephrine and dopamine secreting pheochromocytoma. Glucose and insulin response to oral glucose and C-peptide secretion after glucagon i.v. were evaluated before and after alpha-blockade with phenoxybenzamine. Alpha-blocking treatment restored the inhibited basal and stimulated C-secretion but did not normalize glucose tolerance. After tumor removal metabolic abnormalities were normalized, confirming the role of endogenous catecholamine excess in the pathogenesis of our patient's glucose intolerance.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2075789     DOI: 10.1007/BF02581338

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  9 in total

Review 1.  Physiology and pathophysiology of the human sympathoadrenal neuroendocrine system.

Authors:  P E Cryer
Journal:  N Engl J Med       Date:  1980-08-21       Impact factor: 91.245

2.  Improved safety of glucagon testing for pheochromocytoma by prior alpha-receptor blockade. A controlled trial in a patient with a mixed ganglioneuroma/pheochromocytoma.

Authors:  W J Elliott; M B Murphy; F H Straus; J Jarabak
Journal:  Arch Intern Med       Date:  1989-01

3.  Inhibition of insulin secretion by serotonin and dopamine: species variation.

Authors:  K E Quickel; J M Feldman; H E Lebovitz
Journal:  Endocrinology       Date:  1971-11       Impact factor: 4.736

4.  Inhibition of insulin secretion by catecholamines in pheochromocytoma.

Authors:  J A Colwell
Journal:  Ann Intern Med       Date:  1969-08       Impact factor: 25.391

5.  Insulin and glucagon responses in subjects with pheochromocytoma: effect of alpha adrenergic blockade.

Authors:  J E Vance; K D Buchanan; D O'Hara; R H Williams; D Porte
Journal:  J Clin Endocrinol Metab       Date:  1969-07       Impact factor: 5.958

Review 6.  Current concepts. Pheochromocytoma: diagnosis, localization and management.

Authors:  E L Bravo; R W Gifford
Journal:  N Engl J Med       Date:  1984-11-15       Impact factor: 91.245

7.  Hormonal and metabolic studies in a patient with a pheochromocytoma.

Authors:  D M Turnbull; D G Johnston; K G Alberti; R Hall
Journal:  J Clin Endocrinol Metab       Date:  1980-10       Impact factor: 5.958

8.  Dopamine during alpha- or beta-adrenergic blockade in man. Hormonal, metabolic, and cardiovascular effects.

Authors:  M Lorenzi; J H Karam; E Tsalikian; N V Bohannon; J E Gerich; P H Forsham
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

Review 9.  Phaeochromocytoma.

Authors:  P E Cryer
Journal:  Clin Endocrinol Metab       Date:  1985-02
  9 in total
  1 in total

1.  Tako-tsubo Syndrome as First Manifestation in a Case of Pheochromocytoma Developed From a Non-functional Adrenal Incidentaloma.

Authors:  Pierpaolo Falcetta; Francesca Orsolini; Eleonora Molinaro; Paolo Vitti; Massimo Tonacchera
Journal:  Front Endocrinol (Lausanne)       Date:  2020-02-14       Impact factor: 5.555

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.